| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_863b5001259dc48c0ed81f4dd72128b4 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-92
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-1271
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-31
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-573
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6803
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-12 |
| filingDate |
2018-01-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6be752c17a767e56f0f74614dfa2884b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_59f385fb93c0106f94f367a46bca2938
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fb682a96809ff0b2f4440566f1f23c50 |
| publicationDate |
2019-08-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-110167960-A |
| titleOfInvention |
Human antibody against Staphylococcus aureus hemolysin A toxin |
| abstract |
The present invention provides antibodies that bind to Staphylococcus aureus (S. AUREUS) hemolysin A toxin and methods of use. According to certain embodiments of the invention, the antibody is a fully human antibody that binds to hemolysin A. The antibodies of the present invention are suitable for inhibiting or neutralizing hemolysin A activity, thus providing a means of preventing or treating hemolysin A-related diseases or disorders such as S. aureus infection. In some embodiments, the antibodies of the invention are used to treat at least one symptom or complication of S. aureus infection. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-115894674-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-115894674-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022199527-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112538112-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021052461-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114729033-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022148480-A1 |
| priorityDate |
2017-01-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |